Spinal Fusion Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Summary
GlobalData's Medical Devices sector report, “Spinal Fusion Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Spinal Fusion pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Spinal fusion is a surgical procedure that involves joining two vertebrae in the spine to form a single solid bone, with the involvement of certain devices, in order to relieve pain.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Spinal Fusion under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Spinal Fusion and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Spinal Fusion under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Spinal Fusion Overview
4 Products under Development
4.1 Spinal Fusion - Pipeline Products by Stage of Development
4.2 Spinal Fusion - Pipeline Products by Segment
4.3 Spinal Fusion - Pipeline Products by Territory
4.4 Spinal Fusion - Pipeline Products by Regulatory Path
4.5 Spinal Fusion - Pipeline Products by Estimated Approval Date
4.6 Spinal Fusion - Ongoing Clinical Trials
5 Spinal Fusion - Pipeline Products under Development by Companies
5.1 Spinal Fusion Companies - Pipeline Products by Stage of Development
5.2 Spinal Fusion - Companies Products by Stage of Development
6 Spinal Fusion Companies and Product Overview
6.1 3D Systems Inc Company Overview
6.1.1 3D Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
7.15 Apr 13, 2023: SpineGuard Announces Its Full-year 2022 Financial Results and Its First Quarter 2023 Sales
7.16 Apr 13, 2023: Safe group announces revenues of €1.5 million in Q1 2023
7.17 Apr 12, 2023: Medtronic has a layoff in California
7.18 Apr 06, 2023: Smith & Nephew Notice of First Quarter 2023 Trading Report
7.19 Apr 03, 2023: BioSenic appoints Lieven Huysse MD as Chief Medical Officer
7.20 Mar 31, 2023: OrthoPediatrics Leading Sponsorship at Annual EPOS Meeting
7.21 Mar 28, 2023: Stryker announces Annual Meeting of Shareholders
7.22 Mar 16, 2023: Surgalign to Host its 2023 Annual Meeting of Shareholders on June 1, 2023
7.23 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
7.24 Mar 08, 2023: Geisinger Health Plan, Medacta announce first spinal fusion lifetime guarantee
7.25 Mar 07, 2023: Xtant Medical Announces Fourth Quarter and Full Year 2022 Financial Results
7.26 Mar 06, 2023: Smith & Nephew Announces Annual Financial Report 2022
7.27 Mar 06, 2023: Smith & Nephew Notice of 2023 Annual General Meeting
7.28 Feb 21, 2023: Smith & Nephew Announces Fourth Quarter and Full Year 2022 Results
7.29 Feb 21, 2023: Orthofix Medical Schedules Fourth Quarter Earnings Release and Conference Call for March 6, 2023
7.30 Feb 17, 2023: Bioretec Announces financial statements bulletin 2022
7.31 Feb 14, 2023: Spineway Reports Full Year 2022 Earnings
7.32 Feb 09, 2023: Spinal Elements Appoints Ron Lloyd as President and Chief Executive Officer
7.33 Feb 09, 2023: Spineway announces 2022 annual results
7.34 Feb 03, 2023: Medacta Group reports a robust 20.4% revenue growth in 2022 reaching 437.1 M€
7.35 Jan 27, 2023: BioSenic appoints Yves Sagot as Independent Director
7.36 Jan 25, 2023: Tyber Medical Names James Abraham and Damien Sibilla to Executive Leadership Team
7.37 Jan 24, 2023: IMPLANET Reports 2022 Annual Revenue of €8.0 Million, up 31%
7.38 Jan 18, 2023: BioSenic appoints Dr Carole Nicco as Chief Scientific Officer
7.39 Jan 09, 2023: Orthofix Medical Announces Preliminary SeaSpine and Orthofix 2022 Fourth Quarter and Full-Year Net Sales Results
7.40 Jan 09, 2023: ATEC Announces Select Preliminary Financial 2022 Results, 2023 Guidance and Closing of Flexible, Non-Dilutive Debt Facility
7.41 Jan 09, 2023: SpineGuard Reports a +37% Increase in Q4 2022 Revenue
7.42 Dec 20, 2022: Bioretec's financial information and Annual General Meeting in 2023
7.43 Dec 19, 2022: Spineart and eCential Robotics annouce a partnership to co-develop spine surgery applications and co-market the eCential Robotics' open robotic surgery platform
7.44 Dec 02, 2022: BioSenic appoints Michel Wurm, M.D. as Chief Medical Officer
7.45 Nov 23, 2022: Medtronic Reports Quarterly Earnings
7.46 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
7.47 Nov 22, 2022: Mesoblast Reports Financial Results and Operational Highlights for the Period Ended September 30, 2022
7.48 Nov 21, 2022: Mesoblast Financial Results and Corporate Update Webcast
7.49 Nov 21, 2022: Aurora Spine Announces Third Quarter Fiscal 2022 Financial Results
7.50 Nov 21, 2022: Hogan Lovells advises Stumpf Group on minority investment by funds managed by BDT Capital Partners in Exyte Group
7.51 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
7.52 Nov 10, 2022: Surgalign aims to slash $30M from 2023 spending with planned layoffs
7.53 Nov 09, 2022: Safe announces the convocation of an extraordinary general meeting of the Company to be held on December 16, 2022
7.54 Nov 07, 2022: NuVasive launches tube system and excavation micro for posterior spine surgery
7.55 Oct 30, 2022: Mesoblast Operational and Financial Highlights for Quarter Ended September 30, 2022
7.56 Oct 27, 2022: Xtant Medical to Issue Third Quarter 2022 Financial Results on November 3, 2022
7.57 Oct 25, 2022: Orthofix Medical Schedules Third Quarter Earnings Release and Conference Call for November 3, 2022
7.58 Oct 19, 2022: Allosource Announces Dean Elliott as New President and CEO
7.59 Oct 12, 2022: Aurora Spine Corporation to Attend the North American Spine Society Annual Meeting
7.60 Oct 11, 2022: Kuros Biosciences to present positive clinical data for MagnetOs at NASS 2022 Annual Meeting
7.61 Oct 11, 2022: Orthofix Announces Preliminary Third Quarter and Year-To-Date 2022 Net Sales Results
7.62 Oct 10, 2022: ATEC Announces Select Preliminary Third Quarter 2022 Financial Results and Raises Guidance
7.63 Oct 06, 2022: Safe group announces its first semester financial results and Q3 sales
7.64 Oct 06, 2022: Integra LifeSciences appoints Harvinder Singh as Executive Vice President, President Of Co.''s International Business
7.65 Oct 06, 2022: Integra LifeSciences Announces Key Executive Appointment
7.66 Oct 04, 2022: Exactech Names New Chief Financial Officer
7.67 Sep 20, 2022: Implanet Publishes its 2022 Half-year Results
7.68 Sep 14, 2022: Orthofix Medical Announces Participation in Upcoming Sidoti Virtual Investor Conference
7.69 Sep 12, 2022: NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting
7.70 Sep 07, 2022: Bone Therapeutics reports half year 2022 results
7.71 Sep 07, 2022: Medtronic to appear at September investor conferences
7.72 Aug 30, 2022: ATEC to Participate in Upcoming Investor Conferences
7.73 Aug 30, 2022: Mesoblast Reports Financial Results and Operational Highlights for Fiscal Year Ended June 30, 2022
7.74 Aug 23, 2022: New Chief Financial Officer Appointment Strengthens Spineology’s Executive Leadership Team
7.75 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
7.76 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
7.77 Aug 12, 2022: Sintx Technologies Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
7.78 Aug 09, 2022: Mesoblast shares slide on $65m capital raise announcement
7.79 Aug 09, 2022: Kuros Biosciences reports results for the first six months of 2022
7.80 Aug 04, 2022: ATEC Reports Second Quarter 2022 Financial Results and Increases Full-Year Revenue Guidance
7.81 Aug 03, 2022: Orthopediatrics Reports Second Quarter 2022 Financial Results and Increases 2022 Revenue Guidance
7.82 Aug 02, 2022: Allosource Announces President and CEO Retirement
7.83 Aug 02, 2022: Zimmer Biomet Announces Second Quarter 2022 Financial Results
7.84 Jul 29, 2022: Medacta Group reports 19.0% growth of half-year revenue
7.85 Jul 28, 2022: Smith+Nephew Second Quarter and First Half 2022 Results
7.86 Jul 28, 2022: Xtant Medical to Issue Second Quarter 2022 Financial Results on August 4, 2022
7.87 Jul 26, 2022: ATEC to Participate in Upcoming Investor Conferences
7.88 Jul 21, 2022: ATEC to Report Second Quarter 2022 Financial Results on August 4 2022
Table 75: SPIRA Open Matrix ALIF - SPIRA-A 3D Printed Titanium Anterior Lumbar Interbody Fusion Device and HCT/p Demineralized Bone Matrix Versus Medtronic Divergent-L/Perimeter PEEK Anterior Lumbar Interbody Fusion Device and Recombinant Bone Morphogenic Protein-2